Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
snRNA-seq of Adipose Tissue and Senolytics in Older Obese Subjects
NCT05653258Phase 3Recruiting
- Sponsor
- Cedars-Sinai Medical Center
- Start
- Oct 2023
- Primary completion
- Feb 2027
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dasatinib, quercetin in obesity, sponsored by Cedars-Sinai Medical Center. Started Oct 2023; status: recruiting.
02
Drugs
dasatinibquercetin
03
Conditions
obesity
Beyond the preview
Go deeper on NCT05653258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05653258.